NYLIM
AXNX

New York Life Investment Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

New York Life Investment Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-90,074
Closed -$6.27M – 891
2024
Q3 		$6.27M Buy
90,074
+388
+0.4% +$26.6K 0.06% 287
2024
Q2 		$6.03M Buy
89,686
+31,820
+55% +$2.14M 0.06% 279
2024
Q1 		$3.99M Buy
+57,866
New +$3.9M 0.04% 390

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York Life Investment Management's AXNX Position: Q4 2024 in Review

New York Life Investment Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 90,074 shares — an estimated $6.27M sold.

New York Life Investment Management first reported a position in AXNX in Q1 2024 and held it in 3 quarters. The position peaked at $6.27M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • New York Life Investment Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • New York Life Investment Management sold 90,074 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $6.27M.
  • New York Life Investment Management first reported a position in Axonics, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • New York Life Investment Management's Axonics, Inc. Common Stock position peaked at $6.27M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on New York Life Investment Management's 13F filing for Q4 2024, filed 5 Feb 2025.